noscript

News and Announcements

Proteomics International Laboratories Appoints New Director

  • Published October 19, 2015 11:59AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

16th October 2015, ASX Announcement

Life science company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce the appointment of Mr James Moses to the Company’s board as an executive director, effective form today.

Mr Moses has extensive experience in investment markets and the media developed in a career spanning 25 years, including a wealth of expertise in advising emerging small-cap public companies.

He will work closely with the Company’s leadership team to develop and implement appropriate strategies to maximise PILL’s awareness and penetration in investment markets and with external stakeholders.

To read the full announcement, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now